1. (1) The sale or use of a cannabinoid product is prohibited:

   1. (a) except as provided in this chapter; or
   2. (b) unless the United States Food and Drug Administration approves the product.
2. (2) The department shall keep a list of registered cannabinoid products that the department has determined, in accordance with Section 4-41-403, are safe for human consumption.

3. (3)

   1. (a) A person may sell or use a cannabinoid product that is in the list of registered cannabinoid products described in Subsection (2).

   2. (b) An individual may use cannabidiol or a cannabidiol product that is not in the list of registered cannabinoid products described in Subsection (2) if:

      1. (i) the individual purchased the product outside the state; and
      2. (ii) the product's contents do not violate Title 58, Chapter 37, Controlled Substances, or Title 76, Chapter 18, Part 2, Offenses Concerning Controlled Substances.
4. (4) Any marketing for a cannabinoid product shall include a notice to consumers that the product is hemp or CBD and is not cannabis or medical cannabis, as those terms are defined in Section 26B-4-201.

Amended by Chapter 308, 2026 General Session